Tag: Astrazeneca Ovarian Cancer Drug

Astrazeneca ovarian cancer drug Lynparza shown to improve survival chances

pharmanewsdaily- March 18, 2017

Pharma giant AstraZeneca has reported that its ovarian cancer drug Lynparza (olaparib) as a maintenance therapy has considerably improved the survival chances of patients with ... Read More